128 related articles for article (PubMed ID: 35422219)
1. PBX1 Participates in Estrogen-mediated Bladder Cancer Progression and Chemo-resistance Affecting Estrogen Receptors.
Zhao Y; Che J; Tian A; Zhang G; Xu Y; Li S; Liu S; Wan Y
Curr Cancer Drug Targets; 2022; 22(9):757-770. PubMed ID: 35422219
[TBL] [Abstract][Full Text] [Related]
2. Targeting WD repeat domain 5 enhances chemosensitivity and inhibits proliferation and programmed death-ligand 1 expression in bladder cancer.
Zhang J; Zhou Q; Xie K; Cheng L; Peng S; Xie R; Liu L; Zhang Y; Dong W; Han J; Huang M; Chen Y; Lin T; Huang J; Chen X
J Exp Clin Cancer Res; 2021 Jun; 40(1):203. PubMed ID: 34154613
[TBL] [Abstract][Full Text] [Related]
3. Importin-11 overexpression promotes the migration, invasion, and progression of bladder cancer associated with the deregulation of CDKN1A and THBS1.
Zhao J; Shi L; Zeng S; Ma C; Xu W; Zhang Z; Liu Q; Zhang P; Sun Y; Xu C
Urol Oncol; 2018 Jun; 36(6):311.e1-311.e13. PubMed ID: 29602637
[TBL] [Abstract][Full Text] [Related]
4. Coexpression of PBX1 and EMP2 as Prognostic Biomarkers in Estrogen Receptor-Negative Breast Cancer via Data Mining.
Qiu Y; Lu G; Wu Y
J Comput Biol; 2020 Oct; 27(10):1509-1518. PubMed ID: 32216630
[TBL] [Abstract][Full Text] [Related]
5. The enhanced expression of estrogen-related receptor α in human bladder cancer tissues and the effects of estrogen-related receptor α knockdown on bladder cancer cells.
Ye X; Guo J; Zhang H; Meng Q; Ma Y; Lin R; Yi X; Lu H; Bai X; Cheng J
J Cell Biochem; 2019 Aug; 120(8):13841-13852. PubMed ID: 30977157
[TBL] [Abstract][Full Text] [Related]
6. The role of SOX18 in bladder cancer and its underlying mechanism in mediating cellular functions.
Huaqi Y; Caipeng Q; Qiang W; Yiqing D; Tao X
Life Sci; 2019 Sep; 232():116614. PubMed ID: 31260682
[TBL] [Abstract][Full Text] [Related]
7. Tanshinone IIA Inhibits Epithelial-Mesenchymal Transition in Bladder Cancer Cells via Modulation of STAT3-CCL2 Signaling.
Huang SY; Chang SF; Liao KF; Chiu SC
Int J Mol Sci; 2017 Jul; 18(8):. PubMed ID: 28757590
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of lipid metabolism genes and PBX1 in the contralateral breasts of women with estrogen receptor-negative breast cancer.
Wang J; Shidfar A; Ivancic D; Ranjan M; Liu L; Choi MR; Parimi V; Gursel DB; Sullivan ME; Najor MS; Abukhdeir AM; Scholtens D; Khan SA
Int J Cancer; 2017 Jun; 140(11):2484-2497. PubMed ID: 28263391
[TBL] [Abstract][Full Text] [Related]
9. β-asarone inhibits the migration, invasion, and EMT of bladder cancer through activating ER stress.
Liu B; Dan W; Wei Y; Zhang Y; Wang C; Lei Y; Hou T; Zhang Y; Gao Y
Cancer Med; 2023 Jun; 12(12):13610-13622. PubMed ID: 37306628
[TBL] [Abstract][Full Text] [Related]
10. Regulation of breast cancer metastasis by Runx2 and estrogen signaling: the role of SNAI2.
Chimge NO; Baniwal SK; Little GH; Chen YB; Kahn M; Tripathy D; Borok Z; Frenkel B
Breast Cancer Res; 2011; 13(6):R127. PubMed ID: 22151997
[TBL] [Abstract][Full Text] [Related]
11. Enhancer RNA - P2RY2e induced by estrogen promotes malignant behaviors of bladder cancer.
Ding M; Zhan H; Liao X; Li A; Zhong Y; Gao Q; Liu Y; Huang W; Cai Z
Int J Biol Sci; 2018; 14(10):1268-1276. PubMed ID: 30123075
[TBL] [Abstract][Full Text] [Related]
12. ROC1 promotes the malignant progression of bladder cancer by regulating p-IκBα/NF-κB signaling.
Wu Q; Zhou X; Li P; Ding M; You S; Xu Z; Ye J; Chen X; Tan M; Wang J; Wang W; Qiu J
J Exp Clin Cancer Res; 2021 May; 40(1):158. PubMed ID: 33962660
[TBL] [Abstract][Full Text] [Related]
13. Keratin 17 knockdown suppressed malignancy and cisplatin tolerance of bladder cancer cells, as well as the activation of AKT and ERK pathway.
Li C; Su H; Ruan C; Li X
Folia Histochem Cytobiol; 2021; 59(1):40-48. PubMed ID: 33577073
[TBL] [Abstract][Full Text] [Related]
14. m
Liu Y; Zhai E; Chen J; Qian Y; Zhao R; Ma Y; Liu J; Huang Z; Cai S; Chen J
Cancer Commun (Lond); 2022 Apr; 42(4):327-344. PubMed ID: 35261206
[TBL] [Abstract][Full Text] [Related]
15. Hypermethylated in cancer 1 (HIC1) suppresses bladder cancer progression by targeting yes-associated protein (YAP) pathway.
Zhou X; Zhang P; Han H; Lei H; Zhang X
J Cell Biochem; 2019 Apr; 120(4):6471-6481. PubMed ID: 30417565
[TBL] [Abstract][Full Text] [Related]
16. MET/SMAD3/SNAIL circuit mediated by miR-323a-3p is involved in regulating epithelial-mesenchymal transition progression in bladder cancer.
Li J; Xu X; Meng S; Liang Z; Wang X; Xu M; Wang S; Li S; Zhu Y; Xie B; Lin Y; Zheng X; Liu B; Xie L
Cell Death Dis; 2017 Aug; 8(8):e3010. PubMed ID: 28837140
[TBL] [Abstract][Full Text] [Related]
17. SNHG16 regulates invasion and migration of bladder cancer through induction of epithelial-to-mesenchymal transition.
Chen W; Jiang T; Mao H; Gao R; Zhang H; He Y; Liu C; Chen Q
Hum Cell; 2020 Jul; 33(3):737-749. PubMed ID: 32207096
[TBL] [Abstract][Full Text] [Related]
18. The roles and mechanism of IFIT5 in bladder cancer epithelial-mesenchymal transition and progression.
Huang J; Lo UG; Wu S; Wang B; Pong RC; Lai CH; Lin H; He D; Hsieh JT; Wu K
Cell Death Dis; 2019 Jun; 10(6):437. PubMed ID: 31164632
[TBL] [Abstract][Full Text] [Related]
19. A hydrophobic residue in the TALE homeodomain of PBX1 promotes epithelial-to-mesenchymal transition of gastric carcinoma.
He C; Wang Z; Zhang L; Yang L; Li J; Chen X; Zhang J; Chang Q; Yu Y; Liu B; Zhu Z
Oncotarget; 2017 Jul; 8(29):46818-46833. PubMed ID: 28514754
[TBL] [Abstract][Full Text] [Related]
20. Suppression of ERβ signaling via ERβ knockout or antagonist protects against bladder cancer development.
Hsu I; Chuang KL; Slavin S; Da J; Lim WX; Pang ST; O'Brien JH; Yeh S
Carcinogenesis; 2014 Mar; 35(3):651-61. PubMed ID: 24148819
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
